Example: Heart Attack

Search clinical trials for: Dalteparin

Total 61 results

NCT03559114

Recruiting

PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

Conditions: Traumatic Brain Injury
NCT04850378

Recruiting

Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome

Conditions: Nephrotic Syndrome, Thromboembolic Disease
NCT04731558

Not yet recruiting

Pre- vs Postoperative Thromboprophylaxis for Liver Resection

Conditions: Liver Cancer, Surgery, Thrombosis, Deep Vein, Embolism, Pulmonary, Bleeding
NCT04483960

Recruiting

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial

Conditions: SARS-CoV-2 Infection (COVID-19)
NCT00525057

Completed

Dalteparin in Preventing DVT in Participants With Cancer

Conditions: Bone Sarcoma, Femur Fracture, Lymphoma, Metastatic Neoplasm, Pathologic Fracture, Plasma Cell Myeloma, Soft Tissue Sarcoma
NCT03297359

Recruiting

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Conditions: Cancer, Venous Thromboembolism, Obesity
NCT02744092

Completed

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

Conditions: Cancer, Venous Thromboembolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Blood Clot
NCT04593654

Completed

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

Conditions: Covid19, Thromboembolism
NCT02585713

Completed

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Conditions: Cerebral Vein Thrombosis, Deep Vein Thrombosis, Gonadal Thrombosis, Hepatic Thrombosis, Malignant Neoplasm, Mesenteric Thrombosis, Metastatic Malignant Neoplasm, Portal Vein Thrombosis, Pulmonary Embolism, Renal Vein Thrombosis, Splenic Thrombosis, Venous Thromboembolism
NCT04412304

Completed

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Conditions: Covid-19, Thromboembolic Events, Bleeding
NCT02607111

Completed

A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

Conditions: Kidney Failure
NCT00432796

Active, not recruiting

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Conditions: Stroke
NCT03139487

Recruiting

A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Conditions: Cancer-associated Thrombosis, Esophageal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Pancreatic Cancer, Duodenal Cancer, Esophagogastric Junction Cancer, Malignant Gastrointestinal Stromal Tumor, Ampulla of Vater Cancer, Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)
NCT03045406

Active, not recruiting

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

Conditions: Venous Thromboembolism
NCT01828697

Recruiting

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy

Conditions: Deep Venous Thrombosis, Pulmonary Embolism
NCT00952380

Completed

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Conditions: Venous Thromboembolism
NCT02073682

Completed

Cancer Venous Thromboembolism (VTE)

Conditions: Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Cancer
NCT01050153

Completed

The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma

Conditions: Venous Thromboembolism
NCT00662831

Completed

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients

Conditions: Diabetic Foot Ulcer
NCT00041782

Terminated

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Conditions: Neoplasms, Deep Vein Thrombosis
NCT03218514

Completed

Venous Thromboprophylaxis in Bariatric Surgery

Conditions: Obesity
NCT02334007

Completed

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

Conditions: Venous Thromboembolism, Lung Neoplasms, Pulmonary Embolism
NCT01245998

Completed

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis

Conditions: Superficial Thrombophlebitis
NCT01518465

Terminated

Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

Conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
NCT00216866

Completed

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Conditions: Embolism and Thrombosis